Facilities
The PolyPeptide Group offers its clients great flexibility in peptide manufacturing, with a unique combination of state-of-the-art development laboratories, pilot plants and GMP manufacturing facilities in the USA and Europe.Our facilities total more than 17,500 sq.m. (approx. 190,000 sq.ft.), with solution phase reactors ranging from 160 L to 1000 L in volume and solid phase reactors ranging from 2 L to 280 L in volume.
We have the capacity, technologies, facilities and scientific/regulatory expertise to meet your needs at every stage of your project.
PolyPeptide Laboratories A/S